Six years survival on imatinib with no disease progression after diagnosis of metastatic duodenal gastrointestinal stromal tumour: A case report

Journal of Medical Case Reports

Volumn 2, Issue , 2008, Pages

  Bhattacharya, Sayantan ^a   Choudhury, Amit ^b   Ravi, Srinivasan ^b   Morrissey, John ^c   Mathew, George ^a  

^a GEORGE ELIOT HOSPITAL   (United Kingdom)

^b BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

AGED; ANOREXIA; ARTICLE; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DUODENUM TUMOR; EPIGASTRIC DISCOMFORT; EYE PAIN; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETHARGY; LIVER METASTASIS; MELENA; METASTASIS; NAUSEA; OMENTUM; PANCREAS CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SURVIVAL TIME; WEIGHT REDUCTION;

EID: 45149128807     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-2-110     Document Type: Article

References (11)

1. Sakakura C Hagiwara A Soga K Miyagawa K Nakashima S Yoshikawa T Kin S Nakase Y Yamaoka N Sagara Y Yamagishi H Long-term survival of a case with multiple liver metastases from duodenal gastrointestinal stromal tumor drastically reduced by the treatment with imatinib and hepatectomy World Journal of Gastroenterology 12(17):2793-7. 2006 May 7; 16718773
2. National Institute for Clinical Excellence Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours Technology Appraisal Guidance 86, Guidelines on GIST http://www.nice.org.uk/TA086guidance.
3. Miettinen M Lasota J Gastrointestinal stromal tumors: Pathology and prognosis at different sites Seminars in diagnostic pathology 2006, 23(2):70-83. 10.1053/j.semdp.2006.09.001 17193820
4. Bearzi I Mandolesi A Arduini F Costagliola A Ranaldi R Gastrointestinal stromal tumor. A study of 158 cases: Clinicopathological features and prognostic factors Analytical and Quantitative Cytology and Histology/ The International Academy of Cytology (and) American Society of Cytology 2006, 28(3):137-47. 16786723
5. Emile JF Tabone-Eqlinqer S Theou-Anton N Lemoine A Prognostic value of KIT exon 11 deletions in GISTs Gastroenterology 2006, 131(3):976-8. 10.1053/j.gastro.2006.07.042 16952576
6. Martin J Poveda A Llombart-Bosch A Ramos R Lopez-Guerrero JA Garcia del Muro J Maurel J Calabuig S Guttierrez A Gonzalez de Sande JL Martinez J De Juan A Lainez N Losa F Alija V Escudero P Casado A Garcia P Blanco R Buesa JM Spanish Group for Sarcoma Research Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: A study by the Spanish Group for Sarcoma Research (GEIS) Journal of clinical oncology 23(25):6190-8. 2005 Sep 1; 10.1200/JCO.2005.19.554 16135486
7. Singer S Rubin BP Lux ML Chen CJ Demetri GD Fletcher CD Fletcher JA Prognostic value of KIT mutation type, mitotic activity and histologic subtype in gastrointestinal stromal tumors Journal of clinical oncology 20(18):3898-905. 2002 Sep 15; 10.1200/JCO.2002.03.095 12228211
8. Andersson J Bumming P Meis-Kindblom JM Sihto H Nupponen N Joensuu H Oden A Gustavsson B Kindblom LG Nilsson B Gastrointestinal stromal tumors with KIT exon11 deletions are associated with poor prognosis Gastroenterology 2006, 130(6):1573-81. 10.1053/j.gastro.2006.01.043 16697720
9. Heinrich MC Corless CL Blanke CD Demetri GD Joensuu H Roberts PJ Eisenberg BL von Mehren M Fletcher CD Sandau K McDougall K Ou WB Chen CJ Fletcher JA Molecular correlates of imatinib resistance in gastrointestinal stromal tumors Journal of Clinical Oncology 24(29):4764-74. 2006 Oct 10; 10.1200/JCO.2006.06.2265 16954519
10. Hornick JL Fletcher CD The role of KIT in the management of patients with gastrointestinal stromal tumours Human Pathology 2007, 38(5):679-87. 10.1016/j.humpath.2007.03.001 17437861
11. Lasota J Miettinen M KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs) Seminars in diagnostic pathology 2006, 23(2):91-102. 10.1053/j.semdp.2006.08.006 17193822